The company’s REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.
Epitel raises $12.5M for wearable seizure detection system

The company’s REMI product is currently FDA cleared for in-hospital use, but Epitel plans to expand into ambulatory and in-home care.